How has Amgen's liability for uncertain tax positions noncurrent changed year-over-year?

Amgen's liability for uncertain tax positions noncurrent increased by 14.3% year-over-year, from $2.42B to $2.76B.

What is the long-term trend for Amgen's liability for uncertain tax positions noncurrent?

Over 5 years (2020 to 2025), Amgen's liability for uncertain tax positions noncurrent has grown at a -17.3% compound annual growth rate (CAGR), from $6.97B to $2.69B.

Amgen AMGN Liability For Uncertain Tax Positions Noncurrent

Liability For Uncertain Tax Positions Noncurrent at other companies

PfizerPFE

——

Other financials

Income statement

See full

Revenue$8.6B+5.8%

Gross profit$5.9B+13.4%

Operating income$2.7B+126%

Net income$1.8B+5.1%

EPS (diluted)$3.34+4.4%

Balance sheet

See full

Cash & equivalents$559.0M+10.0%

Total debt$57.3B-0.1%

Total equity$9.2B+48.1%

Total assets$92.5B+3.5%

Cash flow

See full

Operating cash flow$2.2B+57.4%

CapEx$712.0M+73.2%

Free cash flow$1.5B+50.7%

Valuation

See full

Market cap$182.21B+13.3%

Enterprise value$238.97B+9.9%

P/E23.4×-3.7×

P/S4.9×+0.2×

Profitability

See full

Gross margin68.3%+5.3pp

Operating margin28.4%+6.6pp

Net margin21%+3.6pp

Returns & leverage

See full

Return on equity101.3%-4.4pp

Debt / equity6.2×-3.0×

Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:LiabilityForUncertainTaxPositionsNoncurrent.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's liability for uncertain tax positions noncurrent.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amgen's liability for uncertain tax positions noncurrent?: Amgen (AMGN) reported liability for uncertain tax positions noncurrent of $2.76B in Q1 2026.
How has Amgen's liability for uncertain tax positions noncurrent changed year-over-year?: Amgen's liability for uncertain tax positions noncurrent increased by 14.3% year-over-year, from $2.42B to $2.76B.
What is the long-term trend for Amgen's liability for uncertain tax positions noncurrent?: Over 5 years (2020 to 2025), Amgen's liability for uncertain tax positions noncurrent has grown at a -17.3% compound annual growth rate (CAGR), from $6.97B to $2.69B.